Identification of novel biomarkers of response to ATR inhibitors in ARID1A mutant ovarian clear cell carcinoma

被引：1
|
作者：
Stewart, J. R. [1 ]
Baxter, J. [1 ]
Zatreanu, D. [1 ]
Brough, R. [1 ]
Song, F. [1 ]
Konde, A. [1 ]
Krastev, D. [1 ]
Alexander, J. [2 ]
Natrajan, R. [2 ]
Pettitt, S. [1 ]
Banerjee, S. [3 ]
Lord, C. [1 ]
机构：
[1] ICR Inst Canc Res, Chester Beatty Labs, Gene Funct & Breast Canc Res, London, England
[2] ICR Inst Canc Res, Chester Beatty Labs, Breast Canc Res, London, England
[3] Royal Marsden Hosp Chelsea, Gynaecol Dept, London, England
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.04.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3P
引用
收藏
页码：S383 / S384
页数：2
相关论文
共 50 条
  • [31] Synthetic lethal interaction between ARID1A mutation and BET bromodomain inhibition in ovarian clear cell carcinoma
    Berns, Katrien
    Caumanns, Joseph J.
    Hijmans, E. Marielle
    Gennissen, Annemiek
    Evers, Bastiaan
    Wisman, Bea A.
    Meersema, Gert Jan
    Lieftink, Cor
    Beijersbergen, Roderick L.
    Itamochi, Hiroaki
    van der Zee, Ate G.
    de Jong, Steven
    Bernards, Rene
    CANCER RESEARCH, 2017, 77
  • [32] SMARCA4 loss irrelevant for ARID1A mutated ovarian clear cell carcinoma: A case report
    Wagner, Samantha Kay
    Moon, Ashley S.
    Howitt, Brooke E.
    Renz, Malte
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 50
  • [33] Dual blockade of BRD4 and the ATR/WEE1 pathway exploits ARID1A loss in clear cell ovarian cancer
    Kinose, Yasuto
    Xu, Haineng
    Kumar, Sushil
    Kim, Hyoung
    Medvedev, Sergey
    Wang, Xiaolei
    George, Erin
    Shan, Xiaoyin
    Gitto, Sarah
    D'Andrea, Kurt
    Wubbenhorst, Bradley
    Whicker, Margaret
    Hallberg, Dorothy
    Schwartz, Lauren
    Nathanson, Katherine L.
    Mills, Gordon
    Velculescu, Victor E.
    Wang, Tian-Li
    Brown, Eric
    Drapkin, Ronny
    Simpkins, Fiona
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [34] PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K/Akt1-dependent mechanism of synthetic lethality
    Yakovlev, Vasily A.
    Sullivan, Stephanie A.
    Fields, Emma C.
    Temkin, Sarah M.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
    Williamson, Chris T.
    Miller, Rowan
    Pemberton, Helen N.
    Jones, Samuel E.
    Campbell, James
    Konde, Asha
    Badham, Nicholas
    Rafiq, Rumana
    Brough, Rachel
    Gulati, Aditi
    Ryan, Colm J.
    Francis, Jeff
    Vermulen, Peter B.
    Reynolds, Andrew R.
    Reaper, Philip M.
    Pollard, John R.
    Ashworth, Alan
    Lord, Christopher J.
    NATURE COMMUNICATIONS, 2016, 7
  • [36] Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma
    Katagiri, Atsuko
    Nakayama, Kentaro
    Rahman, Mohammed Tanjimur
    Rahman, Munmun
    Katagiri, Hiroshi
    Nakayama, Naomi
    Ishikawa, Masako
    Ishibashi, Tomoka
    Iida, Kouji
    Kobayashi, Hiroshi
    Otsuki, Yoshiro
    Nakayama, Satoru
    Miyazaki, Kohji
    MODERN PATHOLOGY, 2012, 25 (02) : 282 - 288
  • [37] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Yano, Mitsutake
    Katoh, Tomomi
    Miyazawa, Mariko
    Miyazawa, Masaki
    Ogane, Naoki
    Miwa, Maiko
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
    Chris T. Williamson
    Rowan Miller
    Helen N. Pemberton
    Samuel E. Jones
    James Campbell
    Asha Konde
    Nicholas Badham
    Rumana Rafiq
    Rachel Brough
    Aditi Gulati
    Colm J. Ryan
    Jeff Francis
    Peter B. Vermulen
    Andrew R. Reynolds
    Philip M. Reaper
    John R. Pollard
    Alan Ashworth
    Christopher J. Lord
    Nature Communications, 7
  • [39] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Mitsutake Yano
    Tomomi Katoh
    Mariko Miyazawa
    Masaki Miyazawa
    Naoki Ogane
    Maiko Miwa
    Kosei Hasegawa
    Hisashi Narahara
    Masanori Yasuda
    Scientific Reports, 9
  • [40] Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
    Yano, Mitsutake
    Katoh, Tomomi
    Miyazawa, Mariko
    Miyazawa, Masaki
    Ogane, Naoki
    Miwa, Maiko
    Hasegawa, Kosei
    Narahara, Hisashi
    Yasuda, Masanori
    MODERN PATHOLOGY, 2019, 32
12345